Huntsman (HUN)
(Delayed Data from NYSE)
$22.05 USD
+0.10 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $22.06 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.05 USD
+0.10 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $22.06 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Zacks News
Here's Why You Should Hold Onto Huntsman (HUN) Stock for Now
by Zacks Equity Research
While Huntsman (HUN) is exposed to challenges from soft demand in specific markets and pricing pressures, it gains on actions to grow its downstream specialty and formulation businesses and synergies of acquisitions.
Huntsman's (HUN) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Huntsman's (HUN) second-quarter earnings beat estimates but sales miss the same on lower average selling prices.
Huntsman (HUN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Huntsman (HUN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Huntsman (HUN) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 16.67% and 2.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
LyondellBasell (LYB) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
LyondellBasell (LYB) delivered earnings and revenue surprises of 0.45% and 1.07%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Kronos Worldwide (KRO) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Kronos Worldwide (KRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Huntsman (HUN) Q2 Earnings Expected to Decline
by Zacks Equity Research
Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sasol (SSL) Stock Loses 26% in 2024: Wish to Buy the Drop?
by Nilanjan Choudhury
Sasol Limited's (SSL) focus on free cash flow generation, decarbonization, and operational enhancements positions it well for long-term growth.
Here's Why You Should Hold Onto Huntsman (HUN) Stock for Now
by Zacks Equity Research
While Huntsman (HUN) faces headwinds from soft demand in specific markets and pricing pressures, it gains on actions to grow its downstream specialty and formulation businesses and synergies of acquisitions.
Huntsman (HUN) Gains on Downstream Expansion, Acquisitions
by Zacks Equity Research
While Huntsman (HUN) faces headwinds from soft demand conditions, it benefits from investment in downstream businesses and differentiated product innovation as well as strategic acquisitions.
Huntsman (HUN) Unveils New Innovation Center in Belgium
by Zacks Equity Research
The new 11,000-square-meter facility by Huntsman (HUN) includes a world-scale analytical laboratory, two machine halls and fully equipped and automated product testing areas.
Chemours (CC) Soars 5.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Why You Should Retain Huntsman (HUN) Stock in Your Portfolio
by Zacks Equity Research
While Huntsman (HUN) faces headwinds from demand weakness in certain markets and pricing pressures, it benefits from actions to grow its downstream specialty and formulation businesses and synergies of acquisitions.
Huntsman's (HUN) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Huntsman's (HUN) first-quarter earnings beat estimates while sales miss on lower average selling prices.
Huntsman (HUN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Huntsman (HUN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Albemarle (ALB) Q1 Earnings Lag Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of -25.71% and 3.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Avient (AVNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Avient (AVNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Huntsman (HUN) Q1 Earnings Expected to Decline
by Zacks Equity Research
Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold Onto Huntsman (HUN) Stock For Now
by Zacks Equity Research
While Huntsman (HUN) faces headwinds from demand weakness, it benefits from actions to grow its downstream specialty and formulation businesses and synergies of acquisitions.
Why Is Huntsman (HUN) Down 2.3% Since Last Earnings Report?
by Zacks Equity Research
Huntsman (HUN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kronos Worldwide (KRO) Soars 6.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Kronos Worldwide (KRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Huntsman's (HUN) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Huntsman (HUN) sees lower sales across its segments in the fourth quarter on a decline in selling prices and volumes.
Compared to Estimates, Huntsman (HUN) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Huntsman (HUN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Huntsman (HUN) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of -50% and 5.97%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Countdown to Huntsman (HUN) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Huntsman (HUN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.